Citi has lowered its three-month price forecasts for lithium carbonate and lithium hydroxide to $12,000 per ton each, down from previous estimates of $20,000 and $17,000 respectively. The revision reflects slower growth in battery demand and increasing trade and economic uncertainties. Citi also reduced its lithium price outlook for the next two years due to these factors. In contrast, Mizuho projects lithium carbonate prices to rise to $22,500 per ton by the end of 2027, highlighting differing views over longer time horizons.
The story on Citi's revised lithium price forecasts provides context for readers following cryptocurrency market trends. For readers following cryptocurrencies, here is Pluang's market snapshot as of Nov 02, 2026 18:41 WIB: out of 50 major cryptocurrencies, 5 rose and 44 fell. Notable movers include EGLD at Rp60.369 with a 3.99% decline and 95% sell order activity, GRT at Rp356 with a 3.97% decline and 55% buy order activity, and THETA at Rp2.790 with a 3.89% decline and 61% sell order activity.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
